Form 8-K - Current report:
SEC Accession No. 0001558370-25-001517
Filing Date
2025-02-25
Accepted
2025-02-25 17:00:09
Documents
13
Period of Report
2025-02-19
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K glyc-20250219x8k.htm   iXBRL 8-K 49415
  Complete submission text file 0001558370-25-001517.txt   170970

Data Files

Seq Description Document Type Size
2 EX-101.SCH glyc-20250219.xsd EX-101.SCH 3663
3 EX-101.LAB glyc-20250219_lab.xml EX-101.LAB 15361
4 EX-101.PRE glyc-20250219_pre.xml EX-101.PRE 10380
15 EXTRACTED XBRL INSTANCE DOCUMENT glyc-20250219x8k_htm.xml XML 4642
Mailing Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9708 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 25664548
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)